浙江医药

- 600216

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
浙江医药(600216) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入669,529.79432,287.48225,538.92937,521.69711,280.43
营业收入669,529.79432,287.48225,538.92937,521.69711,280.43
二、营业总成本563,808.23351,165.25177,806.75793,402.45610,334.10
营业成本418,497.55260,159.58127,662.45540,654.07426,378.39
营业税金及附加6,575.403,977.142,286.779,653.726,794.94
销售费用67,369.4845,171.6124,068.07110,019.8284,954.21
管理费用33,364.0920,943.3310,114.7358,635.3037,800.50
财务费用-9,326.39-10,437.30-4,071.64-495.80-286.95
研发费用47,328.1131,350.8817,746.3974,935.3454,693.01
资产减值损失----------
公允价值变动收益2,136.45127.67-214.53-2,153.41-357.82
投资收益536.49-337.25808.05-806.94-1,621.82
其中:对联营企业和合营企业的投资收益-673.57-547.10-245.73-964.29-1,236.13
汇兑收益----------
三、营业利润104,829.4376,199.9645,425.04122,311.0493,707.62
加:营业外收入396.3465.3633.96329.35283.82
减:营业外支出595.12377.1880.751,412.18910.92
其中:非流动资产处置损失----------
四、利润总额104,630.6675,888.1445,378.25121,228.2293,080.53
减:所得税费用17,957.5013,431.036,853.0019,203.0717,224.72
五、净利润86,673.1662,457.1238,525.24102,025.1575,855.81
归属于母公司所有者的净利润93,314.7967,330.6740,908.53116,051.0784,965.18
少数股东损益-6,641.63-4,873.56-2,383.29-14,025.92-9,109.37
六、每股收益
基本每股收益(元/股)0.97000.70000.43001.21000.8800
稀释每股收益(元/股)0.97000.70000.43001.21000.8800
七、其他综合收益2,319.812,828.61912.25-763.54-144.15
八、综合收益总额88,992.9865,285.7339,437.49101,261.6175,711.65
归属于母公司所有者的综合收益总额95,490.6169,987.0441,765.23115,338.0784,826.60
归属于少数股东的综合收益总额-6,497.63-4,701.31-2,327.74-14,076.46-9,114.95
下载全部历史数据到excel中 返回页顶